Frank Bergmann, PhD - Publications

Affiliations: 
Ruprecht-Karls-University Heidelberg, Heidelberg, Baden-Württemberg, Germany 
Area:
Systems Biology, Software
Website:
http://frank-fbergmann.blogspot.com/

103 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Shaikh B, Smith LP, Vasilescu D, Marupilla G, Wilson M, Agmon E, Agnew H, Andrews SS, Anwar A, Beber ME, Bergmann FT, Brooks D, Brusch L, Calzone L, Choi K, et al. BioSimulators: a central registry of simulation engines and services for recommending specific tools. Nucleic Acids Research. PMID 35524558 DOI: 10.1093/nar/gkac331  0.506
2021 Smith LP, Bergmann FT, Garny A, Helikar T, Karr J, Nickerson D, Sauro H, Waltemath D, König M. The simulation experiment description markup language (SED-ML): language specification for level 1 version 4. Journal of Integrative Bioinformatics. 18: 20210021. PMID 35330701 DOI: 10.1515/jib-2021-0021  0.522
2020 Keating SM, Waltemath D, König M, Zhang F, Dräger A, Chaouiya C, Bergmann FT, Finney A, Gillespie CS, Helikar T, Hoops S, Malik-Sheriff RS, Moodie SL, Moraru II, Myers CJ, et al. SBML Level 3: an extensible format for the exchange and reuse of biological models. Molecular Systems Biology. 16: e9110. PMID 32845085 DOI: 10.15252/Msb.20199110  0.535
2020 Xu X, Honda K, Miura N, Hori S, Le Blanc S, Bergmann F, Gaida MM, Volkmar M, Schimmack S, Hackert T, Strobel O, Felix K. Actinin-4 splice variant - a complementary diagnostic and prognostic marker of pancreatic neuroendocrine neoplasms. Journal of Cancer. 11: 2318-2328. PMID 32127958 DOI: 10.7150/Jca.37503  0.337
2019 Xie L, Xia L, Klaiber U, Sachsenmaier M, Hinz U, Bergmann F, Strobel O, Büchler MW, Neoptolemos JP, Fortunato F, Hackert T. Effects of neoadjuvant FOLFIRONOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma. Oncotarget. 10: 7276-7287. PMID 31921387 DOI: 10.18632/Oncotarget.27399  0.319
2019 Klupp F, Klauss M, Rahbari NN, Felix K, Hinz U, Manglberger I, Bergmann F, Gaida MM, Hackert T, Strobel O, Büchler MW. Volume changes of the pancreatic head remnant after distal pancreatectomy. Surgery. PMID 31630778 DOI: 10.1016/J.Surg.2019.09.008  0.313
2019 Schimmack S, Yang Y, Felix K, Herbst M, Li Y, Schenk M, Bergmann F, Hackert T, Strobel O. C-reactive protein (CRP) promotes malignant properties in pancreatic neuroendocrine neoplasms. Endocrine Connections. PMID 31234146 DOI: 10.1530/Ec-19-0132  0.303
2019 Ehrenberg KR, Gao J, Oppel F, Frank S, Kang N, Dieter SM, Herbst F, Möhrmann L, Dubash TD, Schulz ER, Strakerjahn H, Giessler KM, Weber S, Oberlack A, Rief EM, ... ... Bergmann F, et al. Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer. Cells. 8. PMID 30744205 DOI: 10.3390/Cells8020142  0.34
2019 Albrecht T, Mehrabi A, Strobel O, Vogel MN, Stenzinger A, Bergmann F, Schirmacher P, Goeppert B. [Spindle and giant cell type undifferentiated carcinoma of the distal bile duct: a case report]. Zeitschrift Fur Gastroenterologie. 57: 52-56. PMID 30641603 DOI: 10.1055/A-0784-8763  0.31
2019 Yang S, Tang W, He P, Wang L, Gaedcke J, Ghadim BM, Ströbel P, Azizian A, Gaida MM, Bergmann F, Alexander HR, Hanna N, Hussain SP. Abstract C61: Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-C61  0.348
2019 Strobel O, Lorenz P, Hinz U, Gaida M, Stadler AK, Hank T, Niesen W, Bergmann F, Hackert T, Büchler M. Encouraging observed 5-year survival with upfront resection and adjuvant therapy for pancreatic ductal adenocarcinoma in a large contemporary series Hpb. 21. DOI: 10.1016/J.Hpb.2019.10.1105  0.301
2018 Sagini MN, Zepp M, Bergmann F, Bozza M, Harbottle R, Berger MR. The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment. Genes & Cancer. 9: 114-129. PMID 30108682 DOI: 10.18632/Genesandcancer.173  0.308
2018 Bedaso Y, Bergmann FT, Choi K, Medley K, Sauro HM. A Portable Structural Analysis Library for Reaction Networks. Bio Systems. PMID 29857031 DOI: 10.1016/J.Biosystems.2018.05.008  0.515
2018 Hank T, Hinz U, Tarantino I, Kaiser J, Niesen W, Bergmann F, Hackert T, Büchler MW, Strobel O. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail. The British Journal of Surgery. PMID 29738626 DOI: 10.1002/Bjs.10842  0.342
2018 Felix K, Hinz U, Dobiasch S, Hackert T, Bergmann F, Neumüller M, Gronowitz S, Bergqvist M, Strobel O. Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer. Pancreas. 47: 72-79. PMID 29189449 DOI: 10.1097/Mpa.0000000000000966  0.3
2017 Zhou X, Xie L, Xia L, Bergmann F, Büchler MW, Kroemer G, Hackert T, Fortunato F. RIP3 attenuates the pancreatic damage induced by deletion of ATG7. Cell Death & Disease. 8: e2918. PMID 28703808 DOI: 10.1038/Cddis.2017.313  0.315
2017 Zhou X, Xie L, Bergmann F, Endris V, Strobel O, Büchler MW, Kroemer G, Hackert T, Fortunato F. The bile acid receptor FXR attenuates acinar cell autophagy in chronic pancreatitis. Cell Death Discovery. 3: 17027. PMID 28660075 DOI: 10.1038/Cddiscovery.2017.27  0.33
2017 Strobel O, Lorenz P, Hinz U, Gaida M, Stadler A, Hank T, Niesen W, Bergmann F, Hackert T, Büchler M. Encouraging observed 5-year survival with upfront resection and adjuvant therapy for pancreatic ductal adenocarcinoma in a large contemporary series Pancreatology. 17. DOI: 10.1016/J.Pan.2017.05.267  0.301
2016 Strobel O, Hank T, Hinz U, Bergmann F, Schneider L, Springfeld C, Jäger D, Schirmacher P, Hackert T, Büchler MW. Pancreatic Cancer Surgery: The New R-status Counts. Annals of Surgery. PMID 27918310 DOI: 10.1016/J.Pan.2016.05.254  0.318
2016 Schimmack S, Kneller S, Dadabaeva N, Bergmann F, Taylor A, Hackert T, Werner J, Strobel O. Epithelial to Stromal Re-Distribution of Primary Cilia during Pancreatic Carcinogenesis. Plos One. 11: e0164231. PMID 27783689 DOI: 10.1371/Journal.Pone.0164231  0.329
2016 Felix K, Hauck O, Schnölzer M, Kempf T, Warnken U, Schneider K, Bergmann F, Fritz S, Werner J. Identification of Novel Serum Autoantibodies for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Ductal Adenocarcinoma. Pancreas. 45: 1309-1319. PMID 27623556 DOI: 10.1097/Mpa.0000000000000647  0.33
2016 Heller A, Angelova AL, Bauer S, Grekova SP, Aprahamian M, Rommelaere J, Volkmar M, Janssen JW, Bauer N, Herr I, Giese T, Gaida MM, Bergmann F, Hackert T, Fritz S, et al. Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas. PMID 27518460 DOI: 10.1097/Mpa.0000000000000673  0.31
2016 Yang S, He P, Wang J, Schetter A, Tang W, Funamizu N, Yanaga K, Uwagawa T, Satoskar AR, Gaedcke J, Bernhardt M, Ghadimi BM, Gaida MM, Bergmann F, Werner J, et al. A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2. Cancer Research. PMID 27197190 DOI: 10.1158/0008-5472.Can-15-2841  0.324
2016 Strauss A, Birdsey M, Fritz S, Schwarz-Bundy BD, Bergmann F, Hackert T, Kauczor HU, Grenacher L, Klauss M. Intraductal Papillary Mucinous Neoplasms of the Pancreas - radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines. The British Journal of Radiology. 20150853. PMID 26959611 DOI: 10.1259/Bjr.20150853  0.314
2016 Offringa R, Poschke I, Volkmar M, Strobel O, Bergmann F, Halama N, Jäger D, Sahin U, Büchler M. Abstract IA46: Towards implementation of T-cell therapy in pancreatic cancer Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-Ia46  0.323
2015 Hackert T, Fritz S, Klauss M, Bergmann F, Hinz U, Strobel O, Schneider L, Büchler MW. Main-duct Intraductal Papillary Mucinous Neoplasm: High Cancer Risk in Duct Diameter of 5 to 9 mm. Annals of Surgery. 262: 875-81. PMID 26583679 DOI: 10.1097/Sla.0000000000001462  0.303
2015 Hucka M, Bergmann FT, Hoops S, Keating SM, Sahle S, Schaff JC, Smith LP, Wilkinson DJ. The Systems Biology Markup Language (SBML): Language Specification for Level 3 Version 1 Core. Journal of Integrative Bioinformatics. 12: 266. PMID 26528564 DOI: 10.1038/Npre.2010.4959.1  0.33
2015 Blank A, Wehweck L, Marinoni I, Boos LA, Bergmann F, Schmitt AM, Perren A. Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors. Virchows Archiv : An International Journal of Pathology. PMID 26384025 DOI: 10.1007/S00428-015-1843-3  0.311
2015 Klau M, Mayer P, Bergmann F, Maier-Hein K, Hase J, Hackert T, Kauczor HU, Grenacher L, Stieltjes B. Correlation of Histological Vessel Characteristics and Diffusion-Weighted Imaging Intravoxel Incoherent Motion-Derived Parameters in Pancreatic Ductal Adenocarcinomas and Pancreatic Neuroendocrine Tumors. Investigative Radiology. 50: 792-7. PMID 26186280 DOI: 10.1097/Rli.0000000000000187  0.312
2015 Hartwig W, Gluth A, Hinz U, Bergmann F, Spronk PE, Hackert T, Werner J, Büchler MW. Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Annals of Surgery. 261: 537-46. PMID 24979606 DOI: 10.1097/Sla.0000000000000791  0.306
2014 Bergmann FT, Adams R, Moodie S, Cooper J, Glont M, Golebiewski M, Hucka M, Laibe C, Miller AK, Nickerson DP, Olivier BG, Rodriguez N, Sauro HM, Scharm M, Soiland-Reyes S, et al. COMBINE archive and OMEX format: one file to share all information to reproduce a modeling project. Bmc Bioinformatics. 15: 369. PMID 25494900 DOI: 10.1186/S12859-014-0369-Z  0.522
2014 Fritz S, Klauss M, Bergmann F, Strobel O, Schneider L, Werner J, Hackert T, Büchler MW. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Annals of Surgery. 260: 848-55; discussion 8. PMID 25379856 DOI: 10.1097/Sla.0000000000000980  0.304
2014 Bergmann F, Aulmann S, Welsch T, Herpel E, Werner J, Schirmacher P, Bläker H. Molecular analysis of pancreatic acinar cell cystadenomas: Evidence of a non-neoplastic nature. Oncology Letters. 8: 852-858. PMID 25009661 DOI: 10.3892/Ol.2014.2163  0.327
2013 Gu H, Fortunato F, Bergmann F, Büchler MW, Whitcomb DC, Werner J. Alcohol exacerbates LPS-induced fibrosis in subclinical acute pancreatitis. The American Journal of Pathology. 183: 1508-17. PMID 24091223 DOI: 10.1016/J.Ajpath.2013.07.023  0.323
2013 Habermehl D, Brecht IC, Bergmann F, Welzel T, Rieken S, Werner J, Schirmacher P, Büchler MW, Debus J, Combs SE. Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection. Radiation Oncology (London, England). 8: 27. PMID 23369246 DOI: 10.1186/1748-717X-8-27  0.303
2013 Oppel F, Ball CR, Hoffmann CM, Dieter SM, Dubash TD, Koch M, Weitz J, Bergmann F, Schmidt M, Abel U, Kalle Cv, Glimm H. Abstract 2295: Succession of transiently active TIC clones drives long-term human pancreatic cancer progression . Cancer Research. 73: 2295-2295. DOI: 10.1158/1538-7445.Am2013-2295  0.323
2013 Sperveslage J, Frank S, Heneweer C, Egberts J, Schniewind B, Buchholz M, Bergmann F, Giese N, Munding J, Hahn S, Kalthoff H, Kloeppel G, Sipos B. 251 : The role of chemokine receptor CCR7 and Its ligands CCL19 and CCL21 in tumor progression of pancreatic ductal adenocarcinoma Cytokine. 63: 302. DOI: 10.1016/J.Cyto.2013.06.254  0.311
2012 Gaida MM, Steffen TG, Günther F, Tschaharganeh DF, Felix K, Bergmann F, Schirmacher P, Hänsch GM. Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors. European Journal of Immunology. 42: 3369-80. PMID 23001948 DOI: 10.1002/Eji.201242628  0.31
2012 Fritz S, Schirren M, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O, Grenacher L, Büchler MW, Werner J. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery. 152: S74-80. PMID 22770954 DOI: 10.1016/J.Surg.2012.05.025  0.33
2012 Habermehl D, Kessel K, Welzel T, Hof H, Abdollahi A, Bergmann F, Rieken S, Weitz J, Werner J, Schirmacher P, Büchler MW, Debus J, Combs SE. Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiation Oncology (London, England). 7: 28. PMID 22385572 DOI: 10.1186/1748-717X-7-28  0.319
2012 Sperveslage J, Frank S, Heneweer C, Egberts J, Schniewind B, Buchholz M, Bergmann F, Giese N, Munding J, Hahn SA, Kalthoff H, Klöppel G, Sipos B. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma. International Journal of Cancer. Journal International Du Cancer. 131: E371-81. PMID 22020953 DOI: 10.1002/Ijc.26502  0.313
2012 Gaida MM, Bach ST, Günther F, Baseras B, Tschaharganeh DF, Welsch T, Felix K, Bergmann F, Hänsch GM, Wente MN. Expression of galectin-3 in pancreatic ductal adenocarcinoma. Pathology Oncology Research : Por. 18: 299-307. PMID 21910036 DOI: 10.1007/S12253-011-9444-1  0.327
2012 Georges R, Bergmann F, Hamdi H, Zepp M, Eyol E, Hielscher T, Berger MR, Adwan H. Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis. Journal of Cellular and Molecular Medicine. 16: 260-72. PMID 21388515 DOI: 10.1111/J.1582-4934.2011.01289.X  0.305
2012 Gu H, Bergmann F, Büchler MW, Whitcomb DC, Werner J, Fortunato F. Pancreatic acini drive early pancreatic fibrosis in the pathogenesis of pancreatitis Pancreatology. 12: 515. DOI: 10.1016/J.Pan.2012.11.046  0.311
2011 Kahlert C, Bergmann F, Beck J, Welsch T, Mogler C, Herpel E, Dutta S, Niemietz T, Koch M, Weitz J. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. Bmc Cancer. 11: 275. PMID 21708005 DOI: 10.1186/1471-2407-11-275  0.332
2011 Hartwig W, Hackert T, Hinz U, Gluth A, Bergmann F, Strobel O, Büchler MW, Werner J. Pancreatic cancer surgery in the new millennium: better prediction of outcome. Annals of Surgery. 254: 311-9. PMID 21606835 DOI: 10.1097/Sla.0B013E31821Fd334  0.325
2011 Waltemath D, Adams R, Beard DA, Bergmann FT, Bhalla US, Britten R, Chelliah V, Cooling MT, Cooper J, Crampin EJ, Garny A, Hoops S, Hucka M, Hunter P, Klipp E, et al. Minimum Information About a Simulation Experiment (MIASE). Plos Computational Biology. 7: e1001122. PMID 21552546 DOI: 10.1371/Journal.Pcbi.1001122  0.504
2011 Ceyhan GO, Timm AK, Bergmann F, Günther A, Aghdassi AA, Demir IE, Mayerle J, Kern M, Lerch MM, Büchler MW, Friess H, Schemmer P. Prophylactic glycine administration attenuates pancreatic damage and inflammation in experimental acute pancreatitis. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. 11: 57-67. PMID 21474970 DOI: 10.1159/000325972  0.311
2011 Hartwig W, Denneberg M, Bergmann F, Hackert T, Hinz U, Strobel O, Büchler MW, Werner J. Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease? American Journal of Surgery. 202: 23-7. PMID 21440887 DOI: 10.1016/J.Amjsurg.2010.06.004  0.319
2011 Bergmann F, Andrulis M, Hartwig W, Penzel R, Gaida MM, Herpel E, Schirmacher P, Mechtersheimer G. Discovered on gastrointestinal stromal tumor 1 (DOG1) is expressed in pancreatic centroacinar cells and in solid-pseudopapillary neoplasms--novel evidence for a histogenetic relationship. Human Pathology. 42: 817-23. PMID 21295818 DOI: 10.1016/J.Humpath.2010.10.005  0.305
2011 El-Ghamari M, Bergmann F, Schmied BM, Weitz J, Ulrich A. Islet cells contribute to pancreatic carcinogenesis in an animal model. Pancreas. 40: 242-6. PMID 21178650 DOI: 10.1097/Mpa.0B013E3182016A08  0.344
2011 Strobel O, Hartwig W, Bergmann F, Hinz U, Hackert T, Grenacher L, Schneider L, Fritz S, Gaida MM, Büchler MW, Werner J. Anaplastic pancreatic cancer: Presentation, surgical management, and outcome. Surgery. 149: 200-8. PMID 20542529 DOI: 10.1016/J.Surg.2010.04.026  0.359
2011 Georges R, Bergmann F, Adwan H, Berger MR. Abstract 5252: Sequential biphasic changes in claudin1 and claudin4 expression correlate to colorectal cancer progression and liver metastasis Cancer Research. 71: 5252-5252. DOI: 10.1158/1538-7445.Am2011-5252  0.314
2011 Waltemath D, Swainston N, Lister AL, Bergmann F, Henkel R, Hoops S, Hucka M, Juty N, Keating S, Knuepfer C, Krause F, Laibe C, Liebermeister W, Lloyd C, Misirli G, et al. SBML Level 3 Package Proposal: Annotation Nature Precedings. 6: 1-1. DOI: 10.1038/Npre.2011.5610.1  0.304
2010 Chandran D, Bergmann FT, Sauro HM. Computer-aided design of biological circuits using TinkerCell. Bioengineered Bugs. 1: 274-81. PMID 21327060 DOI: 10.4161/Bbug.1.4.12506  0.632
2010 Shen SY, Bergmann F, Sauro HM. SBML2TikZ: supporting the SBML render extension in LaTeX. Bioinformatics (Oxford, England). 26: 2794-5. PMID 20829443 DOI: 10.1093/Bioinformatics/Btq512  0.519
2010 Bergmann F, Wandschneider F, Sipos B, Moldenhauer G, Schniewind B, Welsch T, Schirrmacher P, Klöppel G, Altevogt P, Schäfer H, Sebens Müerköster S. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma. Oncology Reports. 24: 909-15. PMID 20811670 DOI: 10.3892/Or.2010.909  0.339
2010 Zhivkova-Galunska M, Adwan H, Eyol E, Kleeff J, Kolb A, Bergmann F, Berger MR. Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines. Cancer Biology & Therapy. 10: 54-64. PMID 20495387 DOI: 10.4161/Cbt.10.1.12161  0.34
2010 Bergmann F, Moldenhauer G, Herpel E, Gaida MM, Strobel O, Werner J, Esposito I, Müerköster SS, Schirmacher P, Kern MA. Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets? Histopathology. 56: 440-8. PMID 20459551 DOI: 10.1111/J.1365-2559.2010.03499.X  0.357
2010 Hartwig W, Duckheim M, Strobel O, Dovzhanskiy D, Bergmann F, Hackert T, Büchler MW, Werner J. LigaSure for pancreatic sealing during distal pancreatectomy. World Journal of Surgery. 34: 1066-70. PMID 20151128 DOI: 10.1007/S00268-010-0458-8  0.339
2010 Hucka M, Bergmann F, Hoops S, Keating SM, Sahle S, Wilkinson DJ. The Systems Biology Markup Language (SBML): Language Specification for Level 3 Version 1 Core (Release 1 Candidate) Nature Precedings. 1-1. DOI: 10.1038/Npre.2010.4123.1  0.316
2010 Sauro HM, Bergmann FT. Software Tools for Systems Biology Systems Biomedicine. 289-314. DOI: 10.1016/B978-0-12-372550-9.00012-2  0.498
2009 Chandran D, Bergmann FT, Sauro HM. TinkerCell: modular CAD tool for synthetic biology. Journal of Biological Engineering. 3: 19. PMID 19874625 DOI: 10.1186/1754-1611-3-19  0.651
2009 Strobel O, Hackert T, Hartwig W, Bergmann F, Hinz U, Wente MN, Fritz S, Schneider L, Büchler MW, Werner J. Survival data justifies resection for pancreatic metastases. Annals of Surgical Oncology. 16: 3340-9. PMID 19777190 DOI: 10.1245/S10434-009-0682-3  0.342
2009 Welsch T, Keleg S, Bergmann F, Bauer S, Hinz U, Schmidt J. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma. Pancreas. 38: 968-76. PMID 19672209 DOI: 10.1097/Mpa.0B013E3181B28D6F  0.336
2009 Kahlert C, Weber H, Mogler C, Bergmann F, Schirmacher P, Kenngott HG, Matterne U, Mollberg N, Rahbari NN, Hinz U, Koch M, Aigner M, Weitz J. Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. British Journal of Cancer. 101: 457-64. PMID 19603023 DOI: 10.1038/Sj.Bjc.6605136  0.363
2009 Smith LP, Bergmann FT, Chandran D, Sauro HM. Antimony: a modular model definition language. Bioinformatics (Oxford, England). 25: 2452-4. PMID 19578039 DOI: 10.1093/Bioinformatics/Btp401  0.643
2009 Ceyhan GO, Demir IE, Rauch U, Bergmann F, Müller MW, Büchler MW, Friess H, Schäfer KH. Pancreatic neuropathy results in "neural remodeling" and altered pancreatic innervation in chronic pancreatitis and pancreatic cancer. The American Journal of Gastroenterology. 104: 2555-65. PMID 19568227 DOI: 10.1038/Ajg.2009.380  0.33
2009 Welsch T, Keleg S, Bergmann F, Degrate L, Bauer S, Schmidt J. Comparative analysis of tumorbiology and CD133 positivity in primary and recurrent pancreatic ductal adenocarcinoma. Clinical & Experimental Metastasis. 26: 701-11. PMID 19488831 DOI: 10.1007/S10585-009-9269-4  0.308
2009 Geismann C, Morscheck M, Koch D, Bergmann F, Ungefroren H, Arlt A, Tsao MS, Bachem MG, Altevogt P, Sipos B, Fölsch UR, Schäfer H, Müerköster SS. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Research. 69: 4517-26. PMID 19435915 DOI: 10.1158/0008-5472.Can-08-3493  0.313
2009 Ceyhan GO, Deucker S, Demir IE, Erkan M, Schmelz M, Bergmann F, Müller MW, Giese T, Büchler MW, Giese NA, Friess H. Neural fractalkine expression is closely linked to pain and pancreatic neuritis in human chronic pancreatitis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 347-61. PMID 19153557 DOI: 10.1038/Labinvest.2008.170  0.318
2009 Bergmann F, Breinig M, Höpfner M, Rieker RJ, Fischer L, Köhler C, Esposito I, Kleeff J, Herpel E, Ehemann V, Friess H, Schirmacher P, Kern MA. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors? The American Journal of Gastroenterology. 104: 171-81. PMID 19098866 DOI: 10.1038/Ajg.2008.33  0.341
2009 Hartwig W, Schneider L, Diener MK, Bergmann F, Büchler MW, Werner J. Preoperative tissue diagnosis for tumours of the pancreas. The British Journal of Surgery. 96: 5-20. PMID 19016272 DOI: 10.1002/Bjs.6407  0.337
2009 Ceyhan GO, Bergmann F, Kadihasanoglu M, Altintas B, Demir IE, Hinz U, Müller MW, Giese T, Büchler MW, Giese NA, Friess H. Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases. Gastroenterology. 136: 177-186.e1. PMID 18992743 DOI: 10.1053/J.Gastro.2008.09.029  0.33
2009 Bergmann F, Ceyhan GO, Rieker RJ, Esposito I, Fischer L, Herpel E, Friess H, Schirmacher P, Kern MA. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates? Human Pathology. 40: 50-7. PMID 18789481 DOI: 10.1016/J.Humpath.2008.06.021  0.34
2009 Kehl T, Hennig R, Bergmann F, Fürstenberger G, Friess H, Krieg P. S2001 Restoration of 15-Lipoxygenase Expression in Pancreatic Tumor Cells Leads to Growth Inhibition and Is Associated with Upregulation of Tumorsuppressor p53 Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)61417-7  0.302
2008 Sauro HM, Bergmann FT. Standards and ontologies in computational systems biology. Essays in Biochemistry. 45: 211-22. PMID 18793134 DOI: 10.1042/Bse0450211  0.533
2008 Hartwig W, Schimmel E, Hackert T, Fortunato F, Bergmann F, Baczako A, Strobel O, Büchler MW, Werner J. A novel animal model of severe pancreatitis in mice and its differences to the rat. Surgery. 144: 394-403. PMID 18707038 DOI: 10.1016/J.Surg.2008.04.006  0.34
2008 Wente MN, Gaida MM, Mayer C, Michalski CW, Haag N, Giese T, Felix K, Bergmann F, Giese NA, Friess H. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. International Journal of Oncology. 33: 297-308. PMID 18636150 DOI: 10.3892/Ijo_00000009  0.372
2008 Esposito I, Born D, Bergmann F, Longerich T, Welsch T, Giese NA, Büchler MW, Kleeff J, Friess H, Schirmacher P. Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis. Plos One. 3: e2539. PMID 18596913 DOI: 10.1371/Journal.Pone.0002539  0.339
2008 Bergmann FT, Sauro HM. Comparing simulation results of SBML capable simulators. Bioinformatics (Oxford, England). 24: 1963-5. PMID 18579569 DOI: 10.1093/Bioinformatics/Btn319  0.484
2008 Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Büchler MW. Most pancreatic cancer resections are R1 resections. Annals of Surgical Oncology. 15: 1651-60. PMID 18351300 DOI: 10.1245/S10434-008-9839-8  0.354
2008 Michalski CW, Maier M, Erkan M, Sauliunaite D, Bergmann F, Pacher P, Batkai S, Giese NA, Giese T, Friess H, Kleeff J. Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells. Plos One. 3: e1701. PMID 18301776 DOI: 10.1371/Journal.Pone.0001701  0.304
2008 Wente MN, Mayer C, Gaida MM, Michalski CW, Giese T, Bergmann F, Giese NA, Büchler MW, Friess H. CXCL14 expression and potential function in pancreatic cancer. Cancer Letters. 259: 209-17. PMID 18054154 DOI: 10.1016/J.Canlet.2007.10.021  0.349
2008 Michalski CW, Oti FE, Erkan M, Sauliunaite D, Bergmann F, Pacher P, Batkai S, Müller MW, Giese NA, Friess H, Kleeff J. Cannabinoids in pancreatic cancer: correlation with survival and pain. International Journal of Cancer. Journal International Du Cancer. 122: 742-50. PMID 17943729 DOI: 10.1002/Ijc.23114  0.308
2007 Michalski CW, Gorbachevski A, Erkan M, Reiser C, Deucker S, Bergmann F, Giese T, Weigand M, Giese NA, Friess H, Kleeff J. Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis. Journal of Translational Medicine. 5: 63. PMID 18053242 DOI: 10.1186/1479-5876-5-63  0.329
2007 Bergmann F, Esposito I, Michalski CW, Herpel E, Friess H, Schirmacher P. Early undifferentiated pancreatic carcinoma with osteoclastlike giant cells: direct evidence for ductal evolution. The American Journal of Surgical Pathology. 31: 1919-25. PMID 18043049 DOI: 10.1097/Pas.0B013E318067Bca8  0.33
2007 Hennig R, Kehl T, Noor S, Ding XZ, Rao SM, Bergmann F, Fürstenberger G, Büchler MW, Friess H, Krieg P, Adrian TE. 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth. Neoplasia (New York, N.Y.). 9: 917-26. PMID 18030360 DOI: 10.1593/Neo.07565  0.374
2007 Esposito I, Seiler C, Bergmann F, Kleeff J, Friess H, Schirmacher P. Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment. Pancreas. 35: 212-7. PMID 17895840 DOI: 10.1097/Mpa.0B013E31805D0190  0.334
2007 Michalski CW, Laukert T, Sauliunaite D, Pacher P, Bergmann F, Agarwal N, Su Y, Giese T, Giese NA, Bátkai S, Friess H, Kuner R. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis. Gastroenterology. 132: 1968-78. PMID 17484889 DOI: 10.1053/J.Gastro.2007.02.035  0.323
2007 Loos M, Bergmann F, Bauer A, Hoheisel JD, Esposito I, Kleeff J, Schirmacher P, Büchler MW, Klöppel G, Friess H. Solid type clear cell carcinoma of the pancreas: differential diagnosis of an unusual case and review of the literature. Virchows Archiv : An International Journal of Pathology. 450: 719-26. PMID 17453235 DOI: 10.1007/S00428-007-0416-5  0.353
2007 Ceyhan GO, Bergmann F, Kadihasanoglu M, Erkan M, Park W, Hinz U, Giese T, Müller MW, Büchler MW, Giese NA, Friess H. The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis. Gut. 56: 534-44. PMID 17047099 DOI: 10.1136/Gut.2006.105528  0.324
2007 Esposito I, Kleeff J, Abiatari I, Shi X, Giese N, Bergmann F, Roth W, Friess H, Schirmacher P. Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer. Journal of Clinical Pathology. 60: 885-95. PMID 16775116 DOI: 10.1136/Jcp.2006.038257  0.35
2007 Bergmann F, Esposito I, Herpel E, Schirmacher P. Pancreatic cancer — Pathology The Chinese-German Journal of Clinical Oncology. 6: 95-101. DOI: 10.1007/S10330-007-0034-3  0.315
2006 Deckard A, Bergmann FT, Sauro HM. Supporting the SBML layout extension. Bioinformatics (Oxford, England). 22: 2966-7. PMID 17038346 DOI: 10.1093/Bioinformatics/Btl520  0.511
2006 Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess H, Schirmacher P. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. The Journal of Pathology. 208: 673-85. PMID 16450333 DOI: 10.1002/Path.1935  0.346
2006 Bergmann FT, Vallabhajosyula RR, Sauro HM. Computational tools for modeling protein networks Current Proteomics. 3: 181-197. DOI: 10.2174/157016406779475380  0.497
2006 Bergmann FT, Sauro HM. SBW - A modular framework for systems biology Proceedings - Winter Simulation Conference. 1637-1645. DOI: 10.1109/WSC.2006.322938  0.473
2005 Bachmann J, Kleeff J, Bergmann F, Shrikhande SV, Hartschuh W, Büchler MW, Friess H. Pancreatic metastasis of Merkel cell carcinoma and concomitant insulinoma: case report and literature review. World Journal of Surgical Oncology. 3: 58. PMID 16137328 DOI: 10.1186/1477-7819-3-58  0.304
2005 Chickarmane V, Paladugu SR, Bergmann F, Sauro HM. Bifurcation discovery tool. Bioinformatics (Oxford, England). 21: 3688-90. PMID 16081475 DOI: 10.1093/Bioinformatics/Bti603  0.551
2004 Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, Bevilacqua G, Campani D. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. Journal of Clinical Pathology. 57: 630-6. PMID 15166270 DOI: 10.1136/Jcp.2003.014498  0.334
2004 Esposito I, Bauer A, Hoheisel JD, Kleeff J, Friess H, Bergmann F, Rieker RJ, Otto HF, Klöppel G, Penzel R. Microcystic tubulopapillary carcinoma of the pancreas: a new tumor entity? Virchows Archiv : An International Journal of Pathology. 444: 447-53. PMID 15014986 DOI: 10.1007/S00428-004-0984-6  0.317
2004 Esposito I, Bergmann F, Penzel R, di Mola FF, Shrikhande S, Büchler MW, Friess H, Otto HF. Oligoclonal T-cell populations in an inflammatory pseudotumor of the pancreas possibly related to autoimmune pancreatitis: an immunohistochemical and molecular analysis. Virchows Archiv : An International Journal of Pathology. 444: 119-26. PMID 14722765 DOI: 10.1007/S00428-003-0949-1  0.314
Show low-probability matches.